AMYLOIDOGENESIS REGULATION BY ACHE IN ALZHEIMER?S DISEASE

$3,181P41FY2009RRNIH

University Of California, San Diego, La Jolla CA

Investigators

Linked publications & trials

Paper 27916382 Paper 27720201 Paper 27706490 Paper 27570571 Paper 27563367 Paper 27563162 Paper 27563154 Paper 27540272 Paper 27522477 Paper 27409243 Paper 27089174 Paper 27066522 Paper 26857634 Paper 26739629 Paper 26632260 Paper 26469938 Paper 26341601 Paper 26108722 Paper 25984248 Paper 25790620 Paper 25742811 Paper 25253262 Paper 25130075 Paper 24806987 Paper 24657727 Paper 24556578 Paper 24435054 Paper 24100964 Paper 23729839 Paper 23666676 Paper 23541894 Paper 23505398 Paper 23421555 Paper 23376397 Paper 23366201 Paper 23288995 Paper 23272834 Paper 23217364 Paper 23104917 Paper 23063666 Paper 23023942 Paper 22965988 Paper 22905037 Paper 22841777 Paper 22841534 Paper 22800534 Paper 22639476 Paper 22408720 Paper 22404998 Paper 22391458 Paper 22255637 Paper 22235289 Paper 22183559 Paper 22169150 Paper 22082669 Paper 22072520 Paper 22068540 Paper 22022240 Paper 22014548 Paper 21988542 Paper 21967898 Paper 21831889 Paper 21811708 Paper 21763714 Paper 21750542 Paper 21744393 Paper 21709855 Paper 21675815 Paper 21632291 Paper 21516262 Paper 21504163 Paper 21397181 Paper 21394717 Paper 21365676 Paper 21308003 Paper 21294851 Paper 21266015 Paper 21151859 Paper 21132109 Paper 21060856 Paper 20816049 Paper 20717975 Paper 20684632 Paper 20626410 Paper 20602360 Paper 20600951 Paper 20600672 Paper 20564048 Paper 20543830 Paper 20532187 Paper 20529877 Paper 20495682 Paper 20484373 Paper 20483334 Paper 20466849 Paper 20454544 Paper 20427241 Paper 20376194 Paper 20300489 Paper 20230909

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The formation of Beta-amyloid plaques in the brain is a key neurodegenerative event in Alzheimer's disease. Small molecules capable of binding to the peripheral anionic site of acetylcholinesterase (AChE) have been shown to inhibit the AChE-induced aggregation of the Beta-amyloid peptide.

View original record on NIH RePORTER →